- Category
- Micro (2024-25)
- Udyam number
- UDYAM-TN-02-0169055

Noble Diagnostics Private Limited
About Noble Diagnostics Private Limited
Data last updated:
Noble Diagnostics Private Limited is a private limited company based in Chetpet, Tamil Nadu, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 22 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U73200TN2019PTC127659.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.15 Cr. It is led by directors Iravatham Sivamani Ramesh and Sureddi Jhansi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Krm Centre 9th Floor No.2 Harrington, Chetpet, Tamil Nadu, India – 600031.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.32 Cr, a growth of 80% compared to the previous year. For the same year it recorded a net loss of ₹41.73 Lakh (net margin -7.8%) and EBITDA of ₹8.91 Lakh (EBITDA margin 1.7%). Revenue has grown at a compounded annual rate (CAGR) of 77% over three years.
The company has about 31 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Noble Diagnostics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0169055). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Noble Diagnostics
Contact details
Noble Diagnostics Private Limited's registered office is in Chetpet, Tamil Nadu.
- Registered AddressKrm Centre 9th Floor No.2 Harrington, Chetpet, Tamil Nadu, India – 600031
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Noble Diagnostics is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Noble Diagnostics Private Limited, buy the company report.
Financials of Noble Diagnostics Private Limited
FY 2024 filings availableNoble Diagnostics Private Limited reported revenue of ₹5.32 Cr (up 80% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 77% over three years, including 80% growth in the latest year. EBITDA rose 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹41.73 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.7% | ||||
| Net Profit Margin | -7.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Noble Diagnostics Private Limited, buy the company report.
Board of directors of Noble Diagnostics Private Limited
Noble Diagnostics has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Iravatham Sivamani Ramesh | Director | 16 Nov 2020 | 6 Years 0 Months | Current |
| Sureddi Jhansi | Director | 01 Dec 2021 | 4 Years 11 Months | Current |
Peer comparison
Noble Diagnostics Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Health Fortune E Private Limited | ₹5.39 Cr (FY 2024) | 523.0% | Jaipur, Rajasthan, India | |||
| Noble Diagnostics Private Limitedthis company | ₹5.32 Cr (FY 2024) | -₹41.73 Lakh | -7.8% | 80.0% | Chetpet, Tamil Nadu, India | |
| Gyd Diagnostics and Reference Laboratories Private Limited | ₹5.3 Cr (FY 2025) | -9.0% | Secunderabad, Telangana, India | |||
| Aran Diagnostic Imaging Private Limited | ₹5.3 Cr (FY 2024) | 23.0% | Coimbatore, Tamil Nadu, India |
To see the full peer comparison of Noble Diagnostics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2020 | 100416133 | Hdfc Bank Limited | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Noble Diagnostics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Noble Diagnostics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Noble Diagnostics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Noble Diagnostics Private Limited has 6 board changes on record since 2020: 2 appointments and 4 cessations. The latest: Sureddi Jhansi was appointed as Director on 01 Dec 2021.
Frequently asked questions
Noble Diagnostics is an active private limited company based in Chetpet, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 22 February 2019 (7+ years old) and is registered under CIN U73200TN2019PTC127659.
Noble Diagnostics has 2 current directors:
- Iravatham Sivamani Ramesh - Director
- Sureddi Jhansi - Director
The latest financial statements of Noble Diagnostics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Noble Diagnostics is U73200TN2019PTC127659. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Noble Diagnostics was incorporated on 22 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Noble Diagnostics by revenue are Health Fortune E Private Limited, Gyd Diagnostics and Reference Laboratories Private Limited, Aran Diagnostic Imaging Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Sureddi Jhansi was appointed as Director on 01 Dec 2021. Ajay Kumar Sakamuri ceased to be Additional Director on 31 Dec 2020. Iravatham Sivamani Ramesh ceased to be Additional Director on 31 Dec 2020. Noble Diagnostics has 6 board changes on record in total.
Yes, Noble Diagnostics is registered as a micro enterprise under Udyam registration (number: UDYAM-TN-02-0169055).
The registered office of Noble Diagnostics is at Krm Centre 9th Floor No.2 Harrington, Chetpet, Tamil Nadu, India – 600031.
Noble Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Noble Diagnostics has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.

